ABCA3 was previously identified as an ER-regulated gene [35], which supports its involvement in breast tumorigenesis, and SPTAN1 was involved in chemotherapy resistance in ovarian cancer [36], which makes this gene a potential target for cancer treatment. The gene discussed is ABCA3; the disease is ovarian carcinoma.